Screening for gestational diabetes: Comparing NICE criteria vs. RCOG criteria recommended during the Covid pandemic – role of HbA1c in GDM screening
Varughese MS, Nayak AU
University Hospital of North Midlands NHS Trust, Stoke on Trent
Mental health case-management significantly reduces hospital admissions and bed days in adults with Type 1 Diabetes Mellitus
Subramaniam Y1, Huda M1, Garrett C1,2
1 Department of Diabetes and Metabolism, Royal London Hospital, Barts Health NHS Trust
2 Department of Psychological Medicine, Royal London Hospital, East London Foundation Trust
Outcomes in patients with lipodystrophy receiving treatment with metreleptin via the National Severe Insulin Resistance Service at Addenbrookes Hospital, Cambridge
Stears AJ; Flanagan CL, Gaff L; Gorman S; Jenkins-Liu C: Savage DB; Williams R; Withers E; O’Rahilly S
Wolfson Centre for Diabetes and Endocrinology, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge
Empagliflozin Reduced the Total Burden of Events Leading to or Prolonging Hospitalisation in EMPA-REG OUTCOME
Gary Solomons1, Silvio E. Inzucchi2, Christoph Wanner3, David Fitchett4, Bernard Zinman5, Stefan D. Anker6, Michaela Mattheus7, Ola Vedin8, Stefan Hantel9, Søren S. Lund10
Factors associated with the difference in HbA1c and FreeStyle Libre Glucose management indicator (GMI) in patients with type 1 diabetes
Priya Sarkar1, Manushri Jain1,2, Tejas Kalaria2, Brett Healey1, Rajeev Raghavan1, Rousseau Gama2
1 Diabetes and Endocrinology, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP
2 Clinical Biochemistry, New Cross Hospital, Black Country Pathology Services, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP
Implementation of Joint Society Guidance on Diabetes (COVID:Diabetes): Dexamethasone/Glucocorticosteroid Therapy In Covid-19 Patients during the COVID-19 Pandemic in a District General Hospital
G Roulston; J Harding J; R Harper; CM McHenry; E McKeever; P McMullan
Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, Belfast
Improving health outcomes in COVID-19 – Use of Flash glucose monitoring in DKA
Reid I, Kirresh O, Golding J, Parthasarathy S
University Hospitals Sussex NHS Foundation Trust
Review: Environmental determinants of type 1 diabetes -> From association to causality
Lauren M. Quinn1, F.S. Wong2, P. Narendran1
1 Institute of Immunology and Immunotherapy, Research College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK 2 Diabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK
Glycaemic tracking of HbA1c in patients with type 1 diabetes can be modified through intensive diabetes support regardless of diabetes duration
Lauren M. Quinn1, R. Thayakaran2, N. Thomas2, K. Nirantharakumar 2, P. Narendran 3,4
1 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
2 Public Health, Epidemiology and Biostatistics, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
3 Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
4 Department of Diabetes, University Hospitals of Birmingham, Birmingham, UK
Effect of Free Style Libre on HbA1c in patients with Diabetes secondary to cystic fibrosis(CFRD) attending cystic Fibrosis centre in a UK centre
Umer Qazi, Muhammad Ali Karamat, Ateeq Syed¹
1 Diabetes and Endocrine Centre , Heartlands Hospital , University Hospitals Birmingham.
